AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug ResistanceView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV evolution in patients initiating antiretroviral therapy during primary infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or DurabilityView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in NorwayView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWHView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to actionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 ResultsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohortView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Achieving the goals of the Fast-Track 90-90-90 strategy in the context of an anti-terrorist operationView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Natural course of hepatitis C virus infection: which factors affect spontaneous clearance of HCV among the Ukrainian population?View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Feasibility and efficacy assessment of hepatitis B vaccination among adult PLWH and vulnerable population in Vinnytsia region, UkraineView Abstract
